MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Clinical trial NCT03896568 · RECRUITING

Trial details

NCT number: NCT03896568
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

IDH1 wt Allele Recurrent Anaplastic Astrocytoma Recurrent Glioblastoma Recurrent Gliosarcoma Recurrent Malignant Glioma

Start date: 2019-02-12
Primary completion: 2027-09-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.